English press releases

4Moving Biotech welcomes Luc Boblet as Chief Executive Officer to lead next phase of growth

LILLE & PARIS, France–(BUSINESS WIRE)– 4Moving Biotech (4MB), a clinical-stage subsidiary of 4P-Pharma specializing in immuno-inflammation and osteoarthritis, is pleased to announce the appointment of...

Swedish Match USA, Inc. Presents to U.S. Food and Drug Administration Advisory Committee to Renew Modified Risk Claim for General Snus

A pioneer in modified risk products, Swedish Match was the first company to receive a modified risk marketing claim and is the first to advance...

MultiSafepay joins Ant International’s Antom to Enhance Digital Payments Services for SMEs in Europe

AMSTERDAM & SINGAPORE–(BUSINESS WIRE)– MultiSafepay (MSP), an Amsterdam-based payment service provider, and Antom global merchant payment services (Antom), a leading payment and digitization services provider...

TauRx Submits UK Marketing Authorisation Application for HMTM as a Treatment for Alzheimer’s Disease

ABERDEEN, Scotland–(BUSINESS WIRE)– TauRx Pharmaceuticals Ltd, a global leader in tau-based research in Alzheimer’s disease (AD), has announced the submission of a UK Marketing Authorisation...

Rimini Street India Places Top 20th in Nation as India’s Great Mid-Size Workplaces 2024

Company once again recognized as a workplace culture leader and employer of choice in the region LAS VEGAS–(BUSINESS WIRE)– Rimini Street, Inc. (Nasdaq: RMNI), a...

Samsung Unveils Versatile Image Sensors for Superior Smartphone Photography

New lineup features industry-leading 200MP and 50MP sensors, bridging the gap between main and sub cameras for enhanced imaging across all angles SEOUL, South Korea–(BUSINESS...

Ant International and Partners Support Almost 100 Million MSMEs, Launches Global “Embrace the Power of Small” Campaign

Ant International announces momentum in serving global MSMEs across its businesses – Alipay+, Antom, WorldFirst, ANEXT Bank and newly-introduced bettr Ant International launches the second...

H.I.G. Capital Announces Sale of Acqua & Sapone to TDR Capital

LONDON–(BUSINESS WIRE)– H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $64 billion of capital under management, is pleased to announce that an affiliate...

Samsung Electronics Announces Successful Building of Industry-First CXL Infrastructure Certified by Red Hat

Samsung can directly verify server configuration elements, including CXL products and software Infrastructure will accelerate product development cycles and provide tailored solutions for customers SEOUL,...

Amazon 2024 Prime Day Dates Revealed by Amazon Fulfilment Centre Employees

Amazon spotlights its fulfilment center employees around the world to share this year’s Prime Day dates LUXEMBOURG–(BUSINESS WIRE)– Prime Day 2024 is coming on 16...

Merck Provides Update on Phase III TrilynX Study in Locally Advanced Head and Neck Cancer

Not intended for UK-, US- or Canada-based media DARMSTADT, Germany–(BUSINESS WIRE)– Merck, a leading science and technology company, today announced the discontinuation of the Phase...

H.I.G. Capital Raises $1.3 Billion for Infrastructure Fund

MIAMI–(BUSINESS WIRE)– H.I.G. Capital (“H.I.G.” or “the Firm”), a leading global alternative asset management firm with $64 billion of capital under management, is pleased to...

Adtran and Iridium strengthen PNT resilience in Europe and Asia-Pacific with Satellite Time and Location technology

News summary: As cyber threats to GNSS grow, network operators are turning to alternative sources of positioning, navigation and timing data Adtran’s Oscilloquartz solutions now...

New Report Exposes the “Dark Underworld” of Illegal Tobacco Trade in Canada, France, the Philippines and the United Kingdom

Buying illegal tobacco products is in danger of becoming normalized, with 43% of adult smokers surveyed comfortable buying cigarettes, even if they know they are...

Takeda Announces Approval of LIVTENCITY® (maribavir) in Japan for Post-Transplant Cytomegalovirus (CMV) Infection/Disease That Is Refractory to Existing Anti-CMV Therapies

LIVTENCITY Is the First and Only Post-Transplant Anti-CMV Treatment Approved in Japan That Targets/Inhibits UL97 Protein Kinase1 CMV Is One of the Most Common and...